While research on BPC-157, particularly in Spain human trials, is ongoing and has shown promising results, it is primarily available for research purposes
Trial of lixisenatide in early parkinsons disease
We explain how each works, what the research supports, how they compare, and what anyone considering peptide therapy needs to understand before moving forward
ScienceDirect , doi:10.1016/j.neubiorev.2015.04.015
Meister and Anderson described this chemistry in detail in their 1983 review in Annual Review of Biochemistry
MT-2 was actually studied as a treatment for erectile dysfunction before tanning became its primary use case (Wessells et al., 1998)